RE
BNTX icon

RBC Europe’s BioNTech BNTX Stock Holding History

RBC Europe’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,383
Closed -$651K – 699
2021
Q3 		$651K Buy
2,383
+765
+47% +$243K 0.03% 176
2021
Q2 		$362K Buy
1,618
+1,148
+244% +$217K 0.02% 234
2021
Q1 		$51.3K Hold
470
– – ﹤0.01% 551
2020
Q4 		$38.3K Buy
470
+70
+18% +$6.87K ﹤0.01% 575
2020
Q3 		$27.7K Buy
+400
New +$28.7K ﹤0.01% 580

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

RBC Europe's BNTX Position: Q4 2021 in Review

RBC Europe sold out of BioNTech (BNTX) in Q4 2021, closing a stake of 2,383 shares — an estimated $651K sold.

RBC Europe first reported a position in BNTX in Q3 2020 and held it in 5 quarters. The position peaked at $651K in Q3 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • RBC Europe reported no remaining BioNTech position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 2,383 BioNTech shares in Q4 2021, an estimated $651K.
  • RBC Europe first reported a position in BioNTech in Q3 2020 and held it in 5 quarters.
  • RBC Europe's BioNTech position peaked at $651K in Q3 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.